Bone Health Technologies Secures US Patent For Osteoboost

Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia.

Bone Wellbeing Innovations (BHT), a main medtech trailblazer creating advancement painless and drug-free solutions for low bone thickness, reported the organization has been granted a fifth patent for Osteoboost — the sole FDA-cleared prescription medical device to treat osteopenia.

The company's unique formula of precision-targeted vibration therapy, which has been clinically proven to reduce the loss of bone density and strength in the lumbar spine in postmenopausal women, is described in detail in the patent, US 12,016,790 B2.

“More than half of the devastating, life-altering fragility fractures happen to the 52 million patients with osteopenia who, prior to Osteoboost, had limited treatment options,” said Laura Yecies, CEO at Bone Health Technologies. “Early intervention at the osteopenia stage to stop the loss of bone is critical to enabling women to stay strong, active, and fracture-free as they age. Doctors desperately need innovation to change the trajectory of this often silent but dangerous condition for postmenopausal women. This patent recognizes the unique approach of our vibration therapy, and will further help us bring Osteoboost to market later this year.”

The research and development firm has also declared the appointment of two new leaders, including returning co-founder Michael Jaasma as chief scientific officer and vice president of clinical and regulatory affairs; and Daniel Beeler as vice president of operations.

“Both Mike and Dan bring decades of experience in medical devices and medtech science to the company, and they couldn’t be joining at a better time. We have thousands of patients waiting for Osteoboost to launch and their experience will make that happen faster,” said Yecies.